The ACSF3 gene helps your cells handle certain small fatty acid building blocks inside mitochondria, the parts of cells that make energy. If the ACSF3 gene does not work well, malonic acid and methylmalonic acid can build up, leading to a condition called combined malonic and methylmalonic aciduria. Many people with ACSF3 variants have few or no symptoms, while some may have low muscle tone, developmental delay, seizures, or periods of illness.
What is a gene?
Genes are stretches of DNA that carry instructions cells can use to make molecules or regulate activities in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can learn more in LearnHub.
Overview
ACSF3Gene function
What if the gene works
The ACSF3 gene helps your mitochondria process malonic acid and methylmalonic acid. Its protein turns these small molecules into forms your cells can use or clear, which supports normal energy balance.
Risk
What if the gene does not work
Variants in the ACSF3 gene can cause combined malonic and methylmalonic aciduria, ranging from no symptoms to developmental, seizure, or movement problems. Milder and more severe variants can influence whether features appear and how noticeable they are.
Treatment
What does that mean for your treatment
No ACSF3-specific treatment or drug choice is currently established. Care is usually supportive and based on a person’s symptoms rather than a targeted therapy. Research on the ACSF3 gene is focused on understanding disease biology, and it has not yet led to a guideline-based treatment.
Conditions associated with ACSF3
Gene function
What if the gene works
Inside mitochondria, your cells use the ACSF3 gene to prepare small molecules for energy work. It helps attach coenzyme A, a helper tag, to malonate and methylmalonate so these compounds can be used in the right way. This supports mitochondrial fatty acid synthesis, which helps keep key energy enzymes ready for daily cell function.
The ACSF3 gene helps your mitochondria add coenzyme A, a helper tag, to malonate and methylmalonate. This changes them into forms your cells can use or process more easily.
One result of ACSF3 activity is malonyl-CoA, an activated building block that feeds mitochondrial fatty acid synthesis. This pathway builds short fatty chains inside mitochondria for routine cell tasks.
This pathway also helps cells make lipoic acid, a small helper used by several enzymes that release energy from food. In this way, ACSF3 supports steady mitochondrial function.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, such as variations in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many ACSF3 gene variants change the enzyme’s shape or stability, so it works less well inside mitochondria, the parts of cells that manage energy. This can reduce the conversion of malonic acid and methylmalonic acid into forms the cell can use, leading to their buildup. Some variants leave partial activity, while more severe variants may leave little or none. That difference can influence how strongly combined malonic and methylmalonic aciduria appears and when it is noticed.
How variants are linked to conditions
Certain inherited variants in the ACSF3 gene cause combined malonic and methylmalonic aciduria, often called CMAMMA. People with two ACSF3 gene variants linked to combined malonic and methylmalonic aciduria may have no clear symptoms, while others have developmental, neurologic, or metabolic concerns. Carrying one variant usually means you are a carrier and do not have the condition.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ACSF3, risk is mainly shaped by whether someone inherits gene changes from both parents, and symptoms can vary a lot even within families. There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risk related to ACSF3.
Inheritance of ACSF3 variants
Variants in the ACSF3 gene are inherited in an autosomal recessive pattern. This means a person usually develops an ACSF3-related condition only when they inherit two disease-causing variants, one from each parent. Parents who each carry one ACSF3 variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with neither variant. This is the main pattern seen in how ACSF3 variants are inherited.
What does my ACSF3 result mean for my family?
For ACSF3, family meaning usually follows a recessive pattern. Brothers and sisters of someone with an ACSF3-related condition may also be affected or may be healthy carriers, and parents are usually carriers as well. More distant relatives can sometimes carry the same gene change too, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
For ACSF3, genetic testing shows how you find out about variants by reading the DNA in a blood or saliva sample and comparing the ACSF3 gene with the usual sequence. Results may identify a benign variant, a variant of uncertain significance, or a pathogenic variant.
When should I consider getting a genetic test?
Testing for changes in the ACSF3 gene may be considered if blood or urine tests show unusually high levels of certain natural acids, or if this rare inherited condition runs in your family. It can also help explain symptoms that suggest a problem with how the body breaks down certain fats.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it reveals depends on the condition and on the specific variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those affected by many genes, genetic information gives context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help make personal experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Common differences in genes can change how the body breaks down, moves, or responds to a drug, which can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in genes can shape a person’s response to medications. It examines gene drug relationships to help explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly the drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more individualized. More information about this topic is available in the LearnHub.
Drugs influenced by the ACSF3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how the body responds to medicines. For now, medication side effects, changes in how a drug seems to work, or any general health concerns are best discussed with your doctor.
History
ACSF3 entered the genetics literature relatively recently, after researchers studying unusual patterns of malonic and methylmalonic acid in some families searched for a shared inherited cause. In 2011, studies identified variants in the ACSF3 gene as the explanation for combined malonic and methylmalonic aciduria, helping clarify a condition that had been recognized biochemically before its genetic basis was clear. From these first observations, research expanded steadily. This discovery helped connect earlier laboratory findings with a specific inherited pattern and brought more consistency to diagnosis in affected families. Since then, ACSF3 has remained mainly of interest in metabolic genetics rather than public awareness, but its identification marked an important step in understanding this rare condition.